U
ECTE

UBS’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

UBS’s Portfolio ECTE Stock Details ECTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$0 Sell
335
-5,957
-95% -$10.7K ﹤0.01% 11126
2014
Q2 		$14K Buy
+6,292
New +$15.6K ﹤0.01% 8560
2014
Q1 		– Sell
-1,192
Closed -$4K – 11186
2013
Q4 		$4K Sell
1,192
-2,748
-70% -$7.67K ﹤0.01% 9779
2013
Q3 		$11K Buy
3,940
+2,035
+107% +$5.51K ﹤0.01% 8761
2013
Q2 		$4K Buy
+1,905
New +$9.99K ﹤0.01% 9494

Other funds holding ECTE

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NPC
National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS's ECTE Position: Q3 2014 in Review

UBS reduced its ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) stake by 95% in Q3 2014, selling an estimated $10.7K and leaving 335 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #11126.

UBS first reported a position in ECTE in Q2 2013 and has held it in 5 quarters since. The position peaked at $14K in Q2 2014. 26 funds tracked by Wall St. Rank hold ECTE as of Q3 2014.

  • UBS held 335 shares of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) worth $0 as of Q3 2014.
  • UBS sold 5,957 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2014, an estimated $10.7K.
  • ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #11126 holding.
  • UBS first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and has held it in 5 quarters since.
  • UBS's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $14K in Q2 2014.
  • 26 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.